hpw - topbar hpw - topbar - diag hpw - topbar xce
 

Fall 2018 

Subscribe

Forward to a Friend

Share   

    

View Archived Issues

 
IN THIS ISSUE
 
 

We examine the wearable technology big data revolution from a global perspective, the innovative strategies to provide access for CAR-T therapies, and the considerations for market access in Catalonia.

 
 
 

 

 
HTA DECISION MAP
 

When HTA Decisions Occur, We Keep You Informed

 
 

Xcenda's HTA Decision Map makes it easy to stay informed. Find out how new products are faring with HTA authorities in:

  • Australia
  • Canada
  • France
  • Germany
  • United Kingdom

 

 
 
HEARD ON THE STREET
 

"The administration is imposing foreign price controls from countries with socialized health care systems that deny their citizens access and discourage innovation. The proposed Medicare Part B model would jeopardize access to medicines for seniors and patients with disabilities living with devastating conditions such as cancer, rheumatoid arthritis, and other autoimmune diseases."

 

Stephen J. Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA) regarding President Trump's Medicare Part B reform which would implement an International Pricing Index (IPI) payment model.

 

 
 
HTA BY THE NUMBERS
 

$17.2 Billion

 

The amount of money the U.S. Department of Health and Human Services (HHS) stated President Trump's proposal for implementing  International Pricing Index (IPI) payment model for Medicare Part B drugs would save over 5 years.

Source: Pharma Blasts Trump Reference Pricing Proposal, PharmExec.com

     
 

For more than 2 decades, companies have turned to Xcenda's leading team of value experts, transforming evidence and market intelligence into effective global market access strategies and solutions. Founded in the application of health outcomes and reimbursement, it's our goal to help prove the inherent worth of client products and services, maximize patient access, and enhance overall brand performance.

Explore our solutions >

 
 

Subscribe to the newsletter written specifically by and for Global HEOR and Market Access professionals.

 
 
 
EDITORS AND CONTRIBUTING AUTHORS
 

EDITOR-IN-CHIEF:
Kellie Meyer, PharmD, MPH
Vice President,
Global Health Economics &
Outcomes Research, Xcenda

MANAGING EDITOR:
Kimberly Riggs
Director,
Global Health Economics &
Outcomes Research, Xcenda

 

EDITORIAL BOARD:

Josep Darba, PhD
Professor | Department of Economics | University of Barcelona

George Papadopoulos, BSc(Hons), GradDipEpi
President | Emerald Corporate Group

Ken Redekop, BSc, MPH, PhD
Associate Professor | Erasmus University Rotterdam

Eldon Spackman, BA, MA, PhD
Co-Director | Institute for Public Health | University of Calgary

Keith Tolley
Director | Tolley Health Economics

Thomas Mittendorf, MSc, PhD
Vice President | Xcenda GmbH

Trent McLaughlin, BSc(Pharm), PhD
Vice President, Real-World Evidence | Xcenda

Michael Eaddy, PharmD, PhD
Vice President, Scientific Consulting | Xcenda

Jay Jackson, PharmD, MPH
Senior Vice President, Consulting Services | Xcenda

CONTRIBUTING AUTHORS:

Chelsey Campbell, PharmD, MBA, MS | Josep Darba, PhD | Kimberly Gittings, PharmD, MS | Marcus Healey, PhD, MBA, MS | Anuja Kanaskar, PharmD | Isabell Kang, PharmD | Kristen Migliaccio-Walle, BS | Victor Nguyen, PharmD, MS | Cynthiya Ruban, PhD, MS | Rebecca Sugarman, MS | Tom Walters, PharmD, MBA, MS

PRODUCTION:

Ellen Olson | Laurie Kozbelt

 

Fall 2018

Subscribe

Forward to a Friend

Share   

    

View Archived Issues

 
 

Connect with AmerisourceBergen:   AmerisourceBergen.com   I   LinkedIn   I   Twitter   I   AmerisourceBergen Insights

Connect with Xcenda:   Xcenda.com   I   LinkedIn   I  Twitter

 
 

This email was sent on behalf of Xcenda by HealthEconomics.Com, 449 S. Mill View Way, Ponte Vedra Beach, FL 32082.
If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here, or send your request in writing to the address above.
Read more about our privacy policy here. You may also request a copy in writing using the address above.